89BIO, INC. (ETNB) Social Stream
89BIO INC (ETNB) Price Targets From Analysts
Use the tables below to see what analysts covering 89BIO INC think about its future price and what recommendations they have for investors and traders.
| Date | Number of Analysts | Highest Target Price | Lowest Target Price | Average Target Price | Current Price | Upside Potential |
|---|---|---|---|---|---|---|
| 2021-11-15 | 8 | $62 | $33 | $50.875 | $11.17 | 355.46% |
| 2022-01-25 | 9 | $62 | $33 | $50.333 | $11.17 | 350.61% |
| 2022-05-04 | 9 | $60 | $33 | $46.888 | $11.17 | 319.77% |
| 2022-05-12 | 9 | $60 | $12 | $41.666 | $11.17 | 273.02% |
| 2022-05-13 | 9 | $60 | $12 | $40.111 | $11.17 | 259.1% |
| 2022-05-16 | 9 | $60 | $10 | $36.444 | $11.17 | 226.27% |
| 2022-06-06 | 9 | $60 | $10 | $32.555 | $11.17 | 191.45% |
| 2022-07-11 | 9 | $46 | $10 | $23.666 | $11.17 | 111.87% |
| 2022-07-28 | 9 | $46 | $10 | $23.333 | $11.17 | 108.89% |
| 2022-08-12 | 8 | $46 | $10 | $23.875 | $11.17 | 113.74% |
| 2022-08-15 | 7 | $29 | $10 | $20.714 | $11.17 | 85.44% |
| 2022-08-16 | 7 | $29 | $10 | $20.428 | $11.17 | 82.88% |
| 2022-08-19 | 7 | $29 | $10 | $20.571 | $11.17 | 84.16% |
| 2022-09-17 | 7 | $29 | $10 | $22.142 | $11.17 | 98.23% |
| 2022-11-14 | 8 | $34 | $11 | $24 | $11.17 | 114.86% |
| 2022-11-21 | 8 | $34 | $11 | $23.875 | $11.17 | 113.74% |
| 2023-02-08 | 8 | $34 | $12 | $24.625 | $11.17 | 120.46% |
| 2023-03-17 | 8 | $34 | $17 | $25.375 | $11.17 | 127.17% |
| 2023-03-20 | 8 | $34 | $17 | $25.125 | $11.17 | 124.93% |
| 2023-03-22 | 7 | $45 | $17 | $27.375 | $11.17 | 145.08% |
| 2023-03-28 | 8 | $50 | $24 | $34.5 | $11.17 | 208.86% |
| 2023-04-13 | 8 | $50 | $24 | $33.875 | $11.17 | 203.27% |
| 2023-05-08 | 8 | $50 | $24 | $34.75 | $11.17 | 211.1% |
| 2023-05-10 | 8 | $50 | $24 | $34.375 | $11.17 | 207.74% |
| 2023-06-06 | 8 | $50 | $24 | $34 | $11.17 | 204.39% |
| 2023-06-25 | 9 | $50 | $24 | $35.666 | $11.17 | 219.3% |
| 2023-06-26 | 9 | $50 | $24 | $36 | $11.17 | 222.29% |
| 2023-07-11 | 9 | $50 | $25 | $37.444 | $11.17 | 235.22% |
| 2023-08-11 | 9 | $50 | $25 | $37.333 | $11.17 | 234.23% |
| 2023-08-15 | 9 | $50 | $25 | $37 | $11.17 | 231.24% |
| 2023-10-10 | 10 | $50 | $25 | $36.9 | $11.17 | 230.35% |
| 2023-10-11 | 10 | $50 | $25 | $34.2 | $11.17 | 206.18% |
| 2023-10-12 | 10 | $50 | $25 | $33.1 | $11.17 | 196.33% |
| 2023-11-10 | 10 | $50 | $24 | $32.8 | $11.17 | 193.64% |
| 2023-11-27 | 9 | $50 | $24 | $32.2 | $11.17 | 188.27% |
| 2023-12-07 | 10 | $50 | $24 | $32.2 | $11.17 | 188.27% |
| 2023-12-20 | 10 | $50 | $24 | $31.5 | $11.17 | 182.01% |
The Trend in the Analyst Price Target
ETNB's average price target has moved down $15.39 over the prior 21 months.
ETNB reports an average of 147.09% for its upside potential over the past 47 weeks.
| Date | Number of Analysts | Highest Target Price | Lowest Target Price | Average Target Price | Share Price | Upside Potential |
|---|---|---|---|---|---|---|
| 2023-06-13 | 9 | 50 | 24 | 35.666 | 22.03 | 61.9% |
| 2023-06-25 | 9 | 50 | 24 | 35.666 | 19.10 | 86.73% |
| 2023-06-26 | 9 | 50 | 25 | 37.500 | 19.22 | 95.11% |
| 2023-08-28 | 10 | 50 | 25 | 36.900 | 16.99 | 117.19% |
| 2023-12-20 | 10 | 50 | 24 | 31.500 | 10.23 | 207.92% |
ETNB Broker Recommendations Summary
| Average Broker Rating | Strong Buy | Buy | Hold | Sell | Strong Sell | Analysts Issuing Recs |
|---|---|---|---|---|---|---|
| 1.3 | 8 | 1 | 1 | 0 | 0 | 10 |
The Trend in the Broker Recommendations
ETNB's average broker recommendation rating worsened by 0.18 over the prior 35 weeks.
The points below can provide you with additional insight regarding what the price target and recommendations metrics in the table above mean for investors.
- In the context of all US stocks, 89BIO INC's upside potential (average analyst target price relative to current price) is higher than 3493.06% of them.
- In the context of all US stocks, 89BIO INC's variance in analysts' estimates is lower than -3291.42% of them.
- In the context of stocks in the small market cap category, 89BIO INC's number of analysts covering the stock is greater than 3730.3% of them.
- ETNB has a greater average analyst price target than 3013.05% of stocks in the small market cap category.
In terms of price targets and recommendations offered by analysts, the stocks in the Pharmaceutical Products industry with the ratings most similar to 89BIO INC are GRTX, RAPT, and PHAT.
View All Top Stocks by Price Target
Is ETNB a Buy, Hold or Sell? See the POWR Ratings now!